Due to the outbreak of coronavirus infection in commercial segment of Russian pharmaceutical market for the first 4 months of 2020 has increased by 12%, writes “Kommersant” with reference to data AlphaRM. The expenses of Russians on drugs for the period increased to an average of 2.5 thousand rubles.
As follows from the data presented by the company AlphaRM, after four months 2020 the pharmaceutical market in Russia in monetary terms increased by 23% compared to the comparable period last year, while the increase in government segment accounted for 48%, commercial — 12%. If considered not in rubles and in packages, the situation is different: commercial segment increased substantially state — 13% vs 10%.
The market volume in this period amounted to 576 billion roubles, two-thirds, as last year, the money of consumers (65%).
From the state 35% market share 19% have subsidized medicines, and 11% — hospital segment, up 5% on the provision of medicines for patients with rare diseases. The average amount of Russians spending on drugs in the first four months of this year 2552 (it’s 12% more than last year).
“The increase in private expenditure on drugs, obviously, is caused by coronavirus infection. While we now see a decline in sales, which is probably for the year will give us a less than 1% growth of the overall market,” said CEO AlphaRM Anna Ermolaeva. The increase in the segment of public procurement, according to her, mainly due to the implementation of the national project on cancer and not with the appearance of coronavirus. Note that private demand for the drugs may still be growing — according to the results of a study conducted by pharmaceutical company STADA, 20% of respondents in Russia are planning to stock up on a specific set of drugs for future use in case of a return to isolation in the future.